Evidence map›Paper›PMID 41195131›Full record

ArticleFrontiers in global women's health2025

Global burden of endometriosis from 1990 to 2021 and projections to 2050: a comprehensive analysis based on the global burden of disease study 2021.

Xiaochuan Yu, Lijuan Shi, Xiaopeng Deng, Yating Zhang, Huali Wang

Abstract read
In one paragraph

Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaochuan Yu *Dalian Women and Children's Medical Center (Group), Dalian, China.
Lijuan Shi *Dalian Medical University, Dalian, China.
Xiaopeng Deng *Dalian Women and Children's Medical Center (Group), Dalian, China.
Yating ZhangDalian Medical University, Dalian, China.
Huali WangDalian Women and Children's Medical Center (Group), Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Endometriosis (EMT) is a prevalent gynecological disorder characterized by chronic pain, menstrual irregularities, and infertility. This study aims to evaluate the global burden of EMT from 1990 to 2021 and to project trends up to 2050. Methods: Data from the Global Burden of Disease (GBD) 2021 database were utilized to analyze mortality, incidence, prevalence, and disability-adjusted life years (DALYs). Trends were assessed using age-standardized rates (ASR) and estimated annual percentage change (EAPC). Future burdens were projected using ARIMA and exponential smoothing models. Results: In 2021, there were 3,447,126 new cases of EMT reported globally. The age-standardized incidence rate (ASIR) experienced a decline of 1.07% from 1990 to 2021, while the age-standardized prevalence rate (ASPR) decreased by 0.95%. The incidence of EMT peaked among women aged 20-24 years, whereas mortality rates increased with advancing age. Projections suggest that by 2050, EMT-related deaths will rise to 68 cases, and the number of disability-adjusted life years (DALYs) will increase to 2,260,948, despite ongoing declines in both ASIR and ASPR. Conclusion: Although the incidence and prevalence rates of EMT are declining, the disease burden remains significant among women of reproductive age. The anticipated rise in mortality and disability-adjusted life years (DALYs) in the future underscores the necessity for targeted public health policies. This study provides evidence to inform global prevention strategies. Future research should investigate the effects of population aging and lifestyle changes on the burden of EMT.

Indexed as

endometriosisglobal burden of diseaseincidencepublic health policytrend projection

Identifiers

PMID41195131
PMCPMC12583065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.